Documentos relacionados

1. [Analysis of genetic variant in a patient with juvenile meterochromic leukodystrophy].
2. Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States.
3. Identification and structural characterization of a pathogenic ARSA missense variant in two consanguineous families from Jammu and Kashmir (India) with late infantile metachromatic leukodystrophy.
4. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges.
5. [Genetic analysis of a patient with late infantile metachromatic leukodystrophy].
6. Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment.
7. Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs.
8. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
9. Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
10. Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots.